# Steroids in Occipital Nerve Block for Treatment of Headache

> **NCT05732532** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 120 (actual)

## Conditions studied

- Headache
- Occipital Nerve Block

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Lidocaine
- **DRUG:** Dexamethasone
- **DRUG:** Normal saline
- **PROCEDURE:** Greater/lesser occipital nerve blocks

## Key facts

- **NCT ID:** NCT05732532
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-17
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05732532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05732532, "Steroids in Occipital Nerve Block for Treatment of Headache". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05732532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*